If the U.S. government declares an influenza pandemic, a new vaccine production facility located in Holly Springs, North Carolina, is certified and ready to go.
New Jersey-based Seqirus announced today that the company's innovative manufacturing facility has successfully achieved all criteria required to establish domestic manufacturing capability for cell-based seasonal and pandemic influenza vaccines as outlined by the Biomedical Advanced Research and Development Authority (BARDA).
North Carolina Vaccine Facility Certified for the Next Pandemic
North Carolina Vaccine Facility Certified for the Next Pandemic
If the U.S. government declares an influenza pandemic, a new vaccine production facility located in Holly Springs, North Carolina, is certified and ready to go.
New Jersey-based Seqirus announced today that the company's innovative manufacturing facility has successfully achieved all criteria required to establish domestic manufacturing capability for cell-based seasonal and pandemic influenza vaccines as outlined by the Biomedical Advanced Research and Development Authority (BARDA).
Meningococcal Vaccination May Offer Gonorrhea Protection
A new study published today in Clinical Infectious Diseases suggests that a meningococcal serogroup B vaccine may offer cross-protection against gonorrhea infection.
This new research joins recent studies from Canada, Norway, and New Zealand that also indicated that meningococcal vaccines might be protective against Neisseria gonorrhoeae.
These findings are essential since Neisseria gonorrhoeae is acquiring increasing resistance to available oral antibiotics, and current screening and treatment approaches have not decreased overall gonorrhea incidence.
Most Neurologic Symptoms Persist for COVID-19 Long Haulers
SARS-CoV-2 vaccination appears to have no positive or negative impact on cognitive function or fatigue
Lung Abnormalities ID’d on Hp-XeMRI in Nonhospitalized Long COVID Patients
Significant difference seen in mean red blood cell:tissue plasma when compared with healthy controls
Pfizer Asks FDA to OK COVID-19 Vaccine for Under 5s
Children younger than 5 years are the only age group in the United States not eligible for COVID-19 vaccination